In vitro release study of timolol from novel hpmc/ha composite film for glaucoma treatment
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: TIGHSAZZADEH, Mo (University of Greenwich, Chemical, Pharmaceutical & Environmental Sciences)
- Co-author(s): Mo Tighsazzadeh
For ocular drug delivery, topical eye drops are the most commonly used dosage form; however, only 5% of the applied dose is absorbed into the eye. Therefore, a more effective drug delivery system is required for severe chronic eye conditions such as glaucoma to provide appropriate bioavailability.
MethodsOptimised 1.5% (w/v) HPMC and 1%.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.